Search

Search Results
Results 17441 - 17450 of 17458 for Depression
  • Drug - 2 Jul 2024
    Consumer Medicine Information (CMI) about Clopine intended for persons living in Australia.
  • Drug - 21 Jun 2024
    Consumer Medicine Information (CMI) about Apidra intended for persons living in Australia.
  • Drug - 16 May 2024
    Consumer Medicine Information (CMI) about Abrilada intended for persons living in Australia.
  • Drug - 24 Apr 2024
    Consumer Medicine Information (CMI) about Lenalidomide Viatris intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Clozaril intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Brenda-35 ED intended for persons living in Australia.
  • Drug - 17 Mar 2023
    Consumer Medicine Information (CMI) about Zoely intended for persons living in Australia.
  • Drug - 28 Mar 2022
    Consumer Medicine Information (CMI) about Clopixol intended for persons living in Australia.
  • Supplier - 6 Sep 2018
    My Possible Self is the first UK mental health app to use content that’s proven to reduce stress, anxiety and mild to moderate depression in eight weeks.
  • Supplier - 1 Jun 2023
    Sage is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.